Akero Therapeutics's total assets for Q3 2025 were $1.01B, a decrease of -9.34% from the previous quarter. DE:0K4 total liabilities were $47.94M for the fiscal quarter, a -42.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.